Cargando…

EGCG Blocked Phenylephrin-Induced Hypertrophy in H9C2 Cardiomyocytes, by Activating AMPK-Dependent Pathway

AMP-activated protein kinase (AMPK) is a key regulator of energy metabolism. Previous studies have shown that activation of AMPK results in suppression of cardiac myocyte hypertrophy via inhibition of the p70S6 kinase (p70S6K) and eukaryotic elongation factor-2 (eEF2) signaling pathways. Epigallocat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yi, Zhao, Li, Qin, Yuan, Wu, Xiao-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Physiological Society and The Korean Society of Pharmacology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422959/ https://www.ncbi.nlm.nih.gov/pubmed/25954124 http://dx.doi.org/10.4196/kjpp.2015.19.3.203

Ejemplares similares

The role of angiopoietin-like protein 4 in phenylephrine-induced cardiomyocyte hypertrophy
por: Sun, Yu, et al.
Publicado: (2019)

Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway
por: Qian, Dongdong, et al.
Publicado: (2022)

JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine
por: Peng, Bohui, et al.
Publicado: (2021)

Slc39a2-Mediated Zinc Homeostasis Modulates Innate Immune Signaling in Phenylephrine-Induced Cardiomyocyte Hypertrophy
por: Fang, Yu, et al.
Publicado: (2021)

An α(2)-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte hypertrophy through mitochondrial-AMPK pathway
por: Weng, Xiaojian, et al.
Publicado: (2020)

Icariin attenuates angiotensin II-induced hypertrophy and apoptosis in H9c2 cardiomyocytes by inhibiting reactive oxygen species-dependent JNK and p38 pathways
por: ZHOU, HENG, et al.
Publicado: (2014)

Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
por: Troncoso, Mayarling Francisca, et al.
Publicado: (2021)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
por: Li, Yiping, et al.
Publicado: (2019)

Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
por: Hernández, Jessica Soto, et al.
Publicado: (2014)

Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy
por: Siti, Hawa Nordin, et al.
Publicado: (2021)

Mitochondria-targeting EGCG derivatives protect H9c2 cardiomyocytes from H(2)O(2)-induced apoptosis: design, synthesis and biological evaluation
por: Sahadevan, Revathy, et al.
Publicado: (2023)

Kazinol B protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced cardiac injury by modulating the AKT/AMPK/Nrf2 signalling pathway
por: Zhang, Qian, et al.
Publicado: (2023)

Resveratrol Inhibits High Glucose-Induced H9c2 Cardiomyocyte Hypertrophy and Damage via RAGE-Dependent Inhibition of the NF-κB and TGF-β1/Smad3 Pathways
por: Zhu, Yanzhou, et al.
Publicado: (2022)

Homocysteine Restricts Copper Availability Leading to Suppression of Cytochrome C Oxidase Activity in Phenylephrine-Treated Cardiomyocytes
por: Zuo, Xiao, et al.
Publicado: (2013)

Stimulation of Na(+)/K(+)-ATPase with an Antibody against Its 4(th) Extracellular Region Attenuates Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy via an AMPK/SIRT3/PPARγ Signaling Pathway
por: Xiong, Siping, et al.
Publicado: (2019)

Paeoniflorin Protects H9c2 Cardiomyocytes against Hypoxia/Reoxygenation Induced Injury via Regulating the AMPK/Nrf2 Signaling Pathway
por: Yu, Wen, et al.
Publicado: (2022)

Pro-apoptotic and migration-suppressing potential of EGCG, and the involvement of AMPK in the p53-mediated modulation of VEGF and MMP-9 expression
por: PARK, SONG YI, et al.
Publicado: (2013)

Lipopolysaccharide modulation of phenylephrine-dependent vasoconstriction is dependent on intercellular communication
por: Ouellette, Y
Publicado: (2008)

Epigallocatechin-3-Gallate (EGCG) Promotes Autophagy-Dependent Survival via Influencing the Balance of mTOR-AMPK Pathways upon Endoplasmic Reticulum Stress
por: Holczer, Marianna, et al.
Publicado: (2018)

Catalase Mediates the Inhibitory Actions of PPARδ against Angiotensin II-Triggered Hypertrophy in H9c2 Cardiomyocytes
por: Hwang, Jung Seok, et al.
Publicado: (2021)

Retracted: Paeoniflorin Protects H9c2 Cardiomyocytes against Hypoxia/Reoxygenation Induced Injury via Regulating the AMPK/Nrf2 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
por: Zhong, Wenliang, et al.
Publicado: (2018)

Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway
por: Wang, Hui‐Bo, et al.
Publicado: (2019)

Refractory hypertension after phenylephrine infusion in cesarean section under subarachnoid block
por: Bansal, Vikash, et al.
Publicado: (2023)

EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice
por: Li, Fang, et al.
Publicado: (2018)

Thymoquinone ameliorates pressure overload‐induced cardiac hypertrophy by activating the AMPK signalling pathway
por: Chen, Heng, et al.
Publicado: (2021)

The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity
por: Li, Jie, et al.
Publicado: (2017)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020)

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway
por: Cui, Yue, et al.
Publicado: (2021)

Calcineurin suppresses AMPK-dependent cytoprotective autophagy in cardiomyocytes under oxidative stress
por: He, H, et al.
Publicado: (2014)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
por: Funamoto, Masafumi, et al.
Publicado: (2022)

Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells
por: Yang, Dafeng, et al.
Publicado: (2017)

Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1–SERCA2 cascade in H9C2 cells
por: Zhao, Jieqiong, et al.
Publicado: (2020)

Ononin alleviates H(2)O(2)-induced cardiomyocyte apoptosis and improves cardiac function by activating the AMPK/mTOR/autophagy pathway
por: Pan, Rongrong, et al.
Publicado: (2021)

Effect of Phenylephrine on the Accommodative System
por: Esteve-Taboada, José J., et al.
Publicado: (2016)

Pressure overload promotes cystatin C secretion of cardiomyocytes to regulate the MAPK signaling pathway and mediate cardiac hypertrophy
por: Shen, Yi, et al.
Publicado: (2020)

EGCG protects the mouse brain against cerebral ischemia/reperfusion injury by suppressing autophagy via the AKT/AMPK/mTOR phosphorylation pathway
por: Wang, Li, et al.
Publicado: (2022)

Apelin Ameliorates High Glucose-Induced Downregulation of Connexin 43 via AMPK-Dependent Pathway in Neonatal Rat Cardiomyocytes
por: Li, Xiaoting, et al.
Publicado: (2018)

Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
por: Wei, Xiao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j3dgimnoi8md588j0j2e1cgh11